Effect of Intensive Fly Control on Trachoma and Ocular Chlamydia Infection in Tanzania

Sponsor
Johns Hopkins University (Other)
Overall Status
Completed
CT.gov ID
NCT00347763
Collaborator
Wellcome Trust (Other)
350
1
2
28
12.5

Study Details

Study Description

Brief Summary

The purpose of this community-based randomized trial was to determine, in trachoma hyper-endemic communities of Tanzania, the added value of intensive spraying to control flies on the fly population and on trachoma and ocular chlamydia infection at 6 months and one year after mass antibiotic treatment.

Condition or Disease Intervention/Treatment Phase
  • Procedure: 10% permethrin in water applied as low volume spray
Phase 4

Detailed Description

Trachoma is the leading infectious cause of blindness in the world. The World Health Organization (WHO), recognizing the important public health impact of trachoma, has adopted a resolution to eliminate blinding trachoma by the year 2020 (3). In order to accomplish this ambitious goal, WHO recommends the use of "SAFE" strategy for countries implementing trachoma control programs. This multi-faceted approach includes Surgery for trichiasis cases, Antibiotics to treat the community pool of infection, Face washing to reduce transmission, and Environmental change.

The environmental change component currently rests largely on efforts to reduce the fly populations in these communities. A pilot study and clinical trial using intense insecticide spraying reduced both flies and trachoma in a trachoma hypo-endemic area of The Gambia. In The Gambia setting, flies appear to be an important vector for trachoma, but it is not clear that flies are equally important in areas with hyper-endemic trachoma, nor is it known if fly control adds value to the provision of mass antibiotic treatment for active trachoma as part of the SAFE strategy.

The purpose of this community-based randomized trial was to determine, in trachoma hyper-endemic communities of Tanzania, the added value of intensive spraying to control flies on the fly population and on trachoma and ocular C. trachomatis infection at 6 months and one year after mass antibiotic treatment. Neighborhoods with intensive spraying (Intervention) and neighborhoods with no spraying (control) all received mass antibiotic treatment with azithromycin immediately prior to the start of the study, enabling us to evaluate the additional impact of fly control on trachoma.

Kongwa district in central Tanzania has been shown to have a high prevalence of active trachoma, and was chosen as the site of this study. We randomized sixteen balozi to receive either mass treatment with azithromycin alone (control), or mass treatment plus an intensive fly spraying program (intervention). Pre-school aged children are the reservoirs of infection and disease within these communities. Therefore, within each balozi, all children aged less than eight served as sentinel markers for the status of trachoma at baseline, 6 months, and one year after baseline. In the eight intervention balozi, 119 children from 87 families were enrolled at baseline, and in the eight control balozi, 183 children from 145 families were enrolled.

The balozis were surveyed and an area surrounding the intervention balozis was targeted for insecticide spray. A solution of 10% permethrin in water was used with a Hudson and MicronAir sprayer machines, At the outset, spraying was carried out every two days for two weeks (attack phase) then once per week (maintenance phase) for the rest of the study.

Two sticky traps, fly paper strips were placed in each balozi to capture flies. The traps were changed every week, and the number of flies captured were counted. If the average number in the intervention balozis exceeded 25% of that in the control balozis, an attack phase, as described above, was reinstituted to keep the fly population low in the intervention group.

The primary outcome was the prevalence of trachoma in the pre-school aged children at 6 months and one year post mass antibiotic treatment.Outcomes are reported based on masked photographic gradings. Secondary outcome was ocular C. trachomatis infection, based on use of Amplicor C. trachomatis qualitative PCR assay.

comparison: Balozi randomized to receive intensive fly spray intervention,compared to Balozi with no fly spray intervention

Study Design

Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Strategies for the Control of Blinding Trachoma: Effect of Fly Spray
Study Start Date :
Jun 1, 2000
Actual Primary Completion Date :
Sep 1, 2002
Actual Study Completion Date :
Oct 1, 2002

Arms and Interventions

Arm Intervention/Treatment
No Intervention: control

no active fly spray intervention

Active Comparator: intervention

aerial spray of permethrin daily for two weeks and weekly as needed by assessment of fly density

Procedure: 10% permethrin in water applied as low volume spray

Outcome Measures

Primary Outcome Measures

  1. clinical trachoma [1 year]

    clinical grading of conjunctival photographs for follicular trachoma

Secondary Outcome Measures

  1. ocular C. trachomatis infection [6 months]

    laboratory assessment of chlamydial DNA on ocular swab; measured as present or absent

Eligibility Criteria

Criteria

Ages Eligible for Study:
12 Months to 8 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Balozi in Chiwe area

  • Sentinel children: age less than 8 years

Exclusion Criteria:
  • Balozi in Chiwe without geographic borders

  • Sentinel children:age more than 8 years

Contacts and Locations

Locations

Site City State Country Postal Code
1 Johns Hopkins University/ Kongwa Trachoma Project Baltimore Maryland United States 21205

Sponsors and Collaborators

  • Johns Hopkins University
  • Wellcome Trust

Investigators

  • Principal Investigator: Sheila West, Johns Hopkins University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00347763
Other Study ID Numbers:
  • WellcomeTrust 059134
First Posted:
Jul 4, 2006
Last Update Posted:
Apr 15, 2013
Last Verified:
May 1, 2004
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 15, 2013